---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-26-000008"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:01:05.300354+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q4 2025 revenue $2.4B (+3%), EPS $1.37; FY26 guidance $9.825-10.025B

## Summary
- Q4 2025 revenue $2.4B (+3% reported, +4% organic); net income $603M (EPS $1.37, +6%).
- Full year 2025 revenue $9.5B (+2% reported, +6% organic); adjusted EPS $6.41 (+8% reported).
- FY 2026 guidance: revenue $9.825-10.025B (organic growth 3-5%); adjusted EPS $7.00-7.10.
- U.S. segment revenue flat organically; International up 7% organic driven by parasiticide and livestock growth.
- Acquired VPG in UK/Ireland; received approvals for long-acting OA pain mAbs Lenivia (dog) and Portela (cat) in Canada/EU.

## SEC filing metadata
- accession: 0001555280-26-000008
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528026000008/0001555280-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528026000008/zts-20260212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-26-000008
- JSON: https://secwatch.observer/filing/0001555280-26-000008.json
- Plain text: https://secwatch.observer/filing/0001555280-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.